Carriers of BRCA1/2 pathogenic variant carriers and their relatives have an increased risk of breast cancer due to their genetic predisposition and are a well-established sub-group of individuals with needs for targeted prevention and care pathways based on a risk-based approach [123]. The gene discussed is BRCA1; the disease is breast carcinoma.